Mark Wong

5.8k total citations
27 papers, 658 citations indexed

About

Mark Wong is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Mark Wong has authored 27 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 5 papers in Surgery. Recurrent topics in Mark Wong's work include Colorectal Cancer Treatments and Studies (10 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Mark Wong is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Mark Wong collaborates with scholars based in Australia, United States and Italy. Mark Wong's co-authors include Howard Gurney, Bavanthi Balakrishnar, Bo Gao, Arthur Clements, Massimo Aglietta, Eric Van Cutsem, Michael J. Overman, Fabio Gelsomino, Rosemary L. Balleine and Bart Neyns and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Mark Wong

26 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Wong Australia 14 393 132 126 123 110 27 658
Emiko Sugiyama Japan 15 395 1.0× 210 1.6× 125 1.0× 257 2.1× 110 1.0× 32 1.0k
Yiqun Zhang United States 17 346 0.9× 84 0.6× 138 1.1× 288 2.3× 49 0.4× 36 805
Anja Henningsson Sweden 8 567 1.4× 182 1.4× 84 0.7× 197 1.6× 32 0.3× 12 889
Frans L. Opdam Netherlands 15 390 1.0× 76 0.6× 153 1.2× 356 2.9× 76 0.7× 58 782
M. Ravic United Kingdom 14 398 1.0× 106 0.8× 92 0.7× 299 2.4× 114 1.0× 36 973
Yon‐Dschun Ko Germany 19 277 0.7× 116 0.9× 151 1.2× 444 3.6× 50 0.5× 63 917
Georgina Meneses‐Lorente United Kingdom 17 260 0.7× 120 0.9× 90 0.7× 340 2.8× 42 0.4× 51 843
Suman Lal Singapore 14 264 0.7× 157 1.2× 58 0.5× 186 1.5× 33 0.3× 26 859
Sander Bins Netherlands 17 688 1.8× 97 0.7× 324 2.6× 376 3.1× 65 0.6× 59 1.2k
Devron R. Shah United Kingdom 7 241 0.6× 77 0.6× 187 1.5× 190 1.5× 41 0.4× 8 599

Countries citing papers authored by Mark Wong

Since Specialization
Citations

This map shows the geographic impact of Mark Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wong more than expected).

Fields of papers citing papers by Mark Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wong. The network helps show where Mark Wong may publish in the future.

Co-authorship network of co-authors of Mark Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wong. A scholar is included among the top collaborators of Mark Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wong. Mark Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Overman, Michael J., Fabio Gelsomino, Massimo Aglietta, et al.. (2024). Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. Journal for ImmunoTherapy of Cancer. 12(5). e008689–e008689. 24 indexed citations
2.
Nagrial, Adnan, Mark Wong, Siobhán O’Neill, et al.. (2024). Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma. Cancers. 16(4). 698–698. 3 indexed citations
3.
Lenz, Heinz‐Josef, Michael J. Overman, Eric Van Cutsem, et al.. (2023). First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142.. Journal of Clinical Oncology. 41(16_suppl). 3550–3550. 4 indexed citations
4.
Khan, Tayyaba, Luke St Heaps, Mark Dexter, et al.. (2021). FISH analysis of brain smears obtained at intraoperative diagnosis – An accurate and fast method to detect 1p/19q-codeletion in gliomas. Journal of Clinical Neuroscience. 92. 115–119. 1 indexed citations
5.
Burgess, Nicholas G., Michael J. Bourke, Mark Wong, et al.. (2021). Outcomes of young patients diagnosed with locally advanced rectal cancer. Journal of Gastrointestinal Oncology. 12(2). 592–601. 3 indexed citations
6.
Pathma‐Nathan, Nimalan, et al.. (2021). Can adjuvant pelvic radiation therapy after local excision or polypectomy for T1 and T2 rectal cancer offer an alternative option to radical surgery?. Clinical and Translational Radiation Oncology. 31. 97–101. 1 indexed citations
7.
Low, Siew‐Kee, Peter Fox, Bavanthi Balakrishnar, et al.. (2020). Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio. The Breast. 54. 229–234. 4 indexed citations
8.
Gebski, Val, Kenneth Micklethwaite, Duncan McLeod, et al.. (2020). Is mucinous histology a prognostic marker in early and advanced colorectal cancer?. Journal of Clinical Oncology. 38(4_suppl). 253–253. 1 indexed citations
9.
Fox, Peter, Bavanthi Balakrishnar, Rosemary L. Balleine, et al.. (2019). Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?. The Breast. 46. 52–57. 9 indexed citations
10.
11.
Overman, Michael J., Francesca Bergamo, Ray McDermott, et al.. (2018). Nivolumab in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): Long-term survival according to prior line of treatment from CheckMate-142.. Journal of Clinical Oncology. 36(4_suppl). 554–554. 38 indexed citations
12.
Fox, Peter, Rosemary L. Balleine, Bo Gao, et al.. (2016). Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study. Clinical Cancer Research. 22(13). 3164–3171. 64 indexed citations
13.
Weller, Michael, Nicholas Butowski, David Tran, et al.. (2016). ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA. Neuro-Oncology. 18(suppl_6). vi17–vi18. 41 indexed citations
14.
Fox, Peter, Bavanthi Balakrishnar, Rosemary L. Balleine, et al.. (2016). Simplified CYP2D6 metabolizer phenotype categorization of patients treated with tamoxifen: Role for endoxifen level monitoring?. Journal of Clinical Oncology. 34(15_suppl). 536–536. 1 indexed citations
15.
16.
Wee, Wen, Ik‐Joo Chung, István Láng, et al.. (2015). Population pharmacokinetics and exposure-safety relationship of nanoliposomal irinotecan (MM-398, nal-IRI) in patients with solid tumors.. Journal of Clinical Oncology. 33(15_suppl). e13588–e13588. 2 indexed citations
17.
Zhou, Fanfan, Jian Zheng, Ling Zhu, et al.. (2013). Functional Analysis of Novel Polymorphisms in the Human SLCO1A2 Gene that Encodes the Transporter OATP1A2. The AAPS Journal. 15(4). 1099–1108. 43 indexed citations
18.
Kloth, Jacqueline S. L., Heinz‐Josef Klümpen, Huixin Yu, et al.. (2013). Predictive Value of CYP3A and ABCB1 Phenotyping Probes for the Pharmacokinetics of Sunitinib: the ClearSun Study. Clinical Pharmacokinetics. 53(3). 261–269. 22 indexed citations
19.
Gu, Di, et al.. (2012). Long-term Ketamine abuse induce interstitial cystitis in rat by impairing bladder epithelium barrier. Neurourology and Urodynamics. 1 indexed citations
20.
Ng, Thomas W. H., et al.. (2012). Histiocytic sarcoma of the brain. Journal of Clinical Neuroscience. 19(10). 1456–1458. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emiko Sugiyama Breakdown of academic impact, for papers by Yiqun Zhang Breakdown of academic impact, for papers by Anja Henningsson Breakdown of academic impact, for papers by Frans L. Opdam Breakdown of academic impact, for papers by M. Ravic Breakdown of academic impact, for papers by Yon‐Dschun Ko Breakdown of academic impact, for papers by Georgina Meneses‐Lorente Breakdown of academic impact, for papers by Suman Lal Breakdown of academic impact, for papers by Sander Bins Breakdown of academic impact, for papers by Devron R. Shah
Rankless by CCL
2026